Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Clin Pharmacol Ther. 2014 Dec 4;97(2):167–176. doi: 10.1002/cpt.5

Figure 1.

Figure 1

Ondansetron plasma logarithmic concentration-time profiles for non-pregnant women, pregnant-women, cord blood, and neonates. Open circles and dashed lines represent observations following administration of the 4 mg dose to the women. Closed circles and solid lines represent observations following administration of the 8 mg dose to the women. Lines connect observations obtained in the same individual.